FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)

MLA

Philippe Gomez, et al. “FDG PET during Radiochemotherapy Is Predictive of Outcome at 1 Year in Non-Small-Cell Lung Cancer Patients: A Prospective Multicentre Study (RTEP2).” European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 6, July 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cda26d4cf97873d1a67a0998adbdae30&authtype=sso&custid=ns315887.

APA

Philippe Gomez, Claire Houzard, Marc-André Mahé, Stéphane Bardet, Khadija Jalali, Caroline Rousseau, Naji Salem, Sébastien Thureau, Romain Modzelewski, Marc-Etienne Meyer, Pierre Olivier, F. Mornex, Delphine Lerouge, Isabelle Brenot-Rossi, Bernard Dubray, Guillaume Faure, Pierre Vera, Agathe Edet-Sanson, Jean-François Ménard, & Sandrine Mezzani-Saillard. (2013). FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2). European Journal of Nuclear Medicine and Molecular Imaging, 41(6).

Chicago

Philippe Gomez, Claire Houzard, Marc-André Mahé, Stéphane Bardet, Khadija Jalali, Caroline Rousseau, Naji Salem, et al. 2013. “FDG PET during Radiochemotherapy Is Predictive of Outcome at 1 Year in Non-Small-Cell Lung Cancer Patients: A Prospective Multicentre Study (RTEP2).” European Journal of Nuclear Medicine and Molecular Imaging 41 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cda26d4cf97873d1a67a0998adbdae30&authtype=sso&custid=ns315887.